ACS-话题@MedSci

#ACS#

406篇内容 | 2856人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1278987, encodeId=320412e898792, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=2011 ACC/AHA NSTACS指南与ESC NSTACS指南的比较, objectType=article, longId=3593, objectId=a00b35938b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a00b35938b, replyNumber=0, likeNumber=37, createdTime=2012-01-03, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a00b35938b, moduleTitle=2011 ACC/AHA NSTACS指南与ESC NSTACS指南的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a00b35938b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278986, encodeId=b64512e898611, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=Acs Nano：李亚平等纳米载体降低肿瘤耐药研究获进展, objectType=article, longId=3477, objectId=483e34e7cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=483e34e7cb, replyNumber=0, likeNumber=36, createdTime=2011-12-14, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=483e34e7cb, moduleTitle=Acs Nano：李亚平等纳米载体降低肿瘤耐药研究获进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=483e34e7cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278985, encodeId=cd1212e8985f0, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=NSTE-ACS诊疗措施推陈出新, objectType=article, longId=3068, objectId=3dff306831, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dff306831, replyNumber=0, likeNumber=36, createdTime=2011-09-08, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dff306831, moduleTitle=NSTE-ACS诊疗措施推陈出新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dff306831)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278984, encodeId=712112e898412, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=RECLOSE-2 ACS研究显示：优化抗血小板治疗仍然任重道远, objectType=article, longId=2617, objectId=05c8261e66, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05c8261e66, replyNumber=0, likeNumber=34, createdTime=2011-06-05, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05c8261e66, moduleTitle=RECLOSE-2 ACS研究显示：优化抗血小板治疗仍然任重道远, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05c8261e66)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278983, encodeId=360c12e8983ed, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=新英格兰：氯吡格雷和阿司匹林在急性冠脉综合征（ACS）中的应用剂量比较, objectType=article, longId=2106, objectId=cd1e210615, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd1e210615, replyNumber=0, likeNumber=43, createdTime=2010-09-11, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd1e210615, moduleTitle=新英格兰：氯吡格雷和阿司匹林在急性冠脉综合征（ACS）中的应用剂量比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd1e210615)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278982, encodeId=3f1f12e898241, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=急性冠状动脉综合征(ACS)诊断及治疗的进展, objectType=article, longId=2017, objectId=5f91201e50, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f91201e50, replyNumber=0, likeNumber=38, createdTime=2010-08-25, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f91201e50, moduleTitle=急性冠状动脉综合征(ACS)诊断及治疗的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f91201e50)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1278981, encodeId=94d212e898191, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, objectTitle=抗血小板在ACS急性期及长期临床中的应用, objectType=article, longId=2010, objectId=39402010c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39402010c9, replyNumber=0, likeNumber=28, createdTime=2010-08-25, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39402010c9, moduleTitle=抗血小板在ACS急性期及长期临床中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39402010c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ACS

2020-05-29

yaanren (审核中...)

前往app查看评论内容

#ACS#

2011 ACC/AHA NSTACS指南与ESC NSTACS指南的比较

2012-01-03

yaanren (审核中...)

前往app查看评论内容

#ACS#

Acs Nano：李亚平等纳米载体降低肿瘤耐药研究获进展

2011-12-14

yaanren (审核中...)

前往app查看评论内容

#ACS#

NSTE-ACS诊疗措施推陈出新

2011-09-08

yaanren (审核中...)

前往app查看评论内容

#ACS#

RECLOSE-2 ACS研究显示：优化抗血小板治疗仍然任重道远

2011-06-05

yaanren (审核中...)

前往app查看评论内容

#ACS#

新英格兰：氯吡格雷和阿司匹林在急性冠脉综合征（ACS）中的应用剂量比较

2010-09-11

yaanren (审核中...)

前往app查看评论内容

#ACS#

急性冠状动脉综合征(ACS)诊断及治疗的进展

2010-08-25

yaanren (审核中...)

前往app查看评论内容

#ACS#

抗血小板在ACS急性期及长期临床中的应用

2010-08-25

科室
- - 订阅+
  - 更多科室
工具
服务